Transcat (NASDAQ:TRNS) released its quarterly earnings data on Tuesday. The scientific and technical instruments company reported $0.35 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.26 by $0.09, Fidelity Earnings reports. Transcat had a return on equity of 12.05% and a net margin of 4.37%.
Transcat stock opened at $24.11 on Wednesday. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.45 and a current ratio of 2.16. Transcat has a 12 month low of $16.90 and a 12 month high of $25.35. The company has a market capitalization of $173.16 million, a price-to-earnings ratio of 33.96, a P/E/G ratio of 2.99 and a beta of 0.90.
Several research firms have commented on TRNS. Zacks Investment Research upgraded Transcat from a “strong sell” rating to a “hold” rating in a research report on Thursday, April 11th. ValuEngine upgraded Transcat from a “hold” rating to a “buy” rating in a research report on Monday, February 4th.
A number of institutional investors have recently added to or reduced their stakes in the business. Wells Fargo & Company MN boosted its position in Transcat by 7.6% in the 1st quarter. Wells Fargo & Company MN now owns 7,703 shares of the scientific and technical instruments company’s stock worth $177,000 after purchasing an additional 547 shares in the last quarter. Hancock Whitney Corp lifted its position in shares of Transcat by 7.3% during the 1st quarter. Hancock Whitney Corp now owns 11,005 shares of the scientific and technical instruments company’s stock valued at $253,000 after buying an additional 750 shares in the last quarter. Marshall Wace North America L.P. lifted its position in shares of Transcat by 157.5% during the 1st quarter. Marshall Wace North America L.P. now owns 1,545 shares of the scientific and technical instruments company’s stock valued at $36,000 after buying an additional 945 shares in the last quarter. O Shaughnessy Asset Management LLC lifted its position in shares of Transcat by 7.2% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 15,038 shares of the scientific and technical instruments company’s stock valued at $286,000 after buying an additional 1,007 shares in the last quarter. Finally, Morgan Stanley purchased a new position in shares of Transcat during the 1st quarter valued at approximately $36,000. Institutional investors and hedge funds own 58.67% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This piece of content was originally reported by Baseball Daily News and is the property of of Baseball Daily News. If you are viewing this piece of content on another website, it was stolen and republished in violation of international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.baseballdailydigest.com/news/2019/05/22/transcat-trns-announces-quarterly-earnings-results.html.
Transcat, Inc provides calibration and laboratory instrument services in North America and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Further Reading: Commodities
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.